Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3

Parnassus Investments, an concern absorption company, released the “Parnassus Core Equity Fund” third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The S&P 500 Index surged successful the 3rd quarter, driven by capitalist optimism that grew connected expectations of monetary easing, beardown user demand, and coagulated firm earnings. The Fund (Investor Shares) returned 2.57% (net of fees) successful the quarter, trailing the S&P 500 Index’s 8.12% return. YTD, the money returned 9.89% compared to 14.83% for the index. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its third-quarter 2025 capitalist letter, Parnassus Core Equity Fund highlighted stocks specified arsenic Thermo Fisher Scientific Inc. (NYSE:TMO). Thermo Fisher Scientific Inc. (NYSE:TMO) offers beingness sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services. The one-month instrumentality of Thermo Fisher Scientific Inc. (NYSE:TMO) was -3.69%, and its shares gained 8.83% of their worth implicit the past 52 weeks. On December 22, 2025, Thermo Fisher Scientific Inc. (NYSE:TMO) banal closed astatine $575.70 per share, with a marketplace capitalization of $216.3 billion.

Parnassus Core Equity Fund stated the pursuing regarding Thermo Fisher Scientific Inc. (NYSE:TMO) successful its 3rd 4th 2025 capitalist letter:

"Thermo Fisher Scientific Inc. (NYSE:TMO), a planetary supplier of pharmaceutical probe instruments and services, recovered from being oversold earlier successful the year, aided by favorable fiscal results and guidance that exceeded muted expectations."

Thermo Fisher Scientific Inc. (NYSE:TMO) is successful 26th presumption connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 121 hedge money portfolios held Thermo Fisher Scientific Inc. (NYSE:TMO) astatine the extremity of the 3rd quarter, up from 117 successful the erstwhile quarter. While we admit the imaginable of Thermo Fisher Scientific Inc. (NYSE:TMO) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In another article, we covered Thermo Fisher Scientific Inc. (NYSE:TMO) and shared the database of champion S&P 500 stocks to buy. In Q3 2025, Thermo Fisher Scientific Inc. (NYSE:TMO) was a coagulated show contributor to Harding Loevner Global Equity Strategy. In addition, delight cheque retired our hedge money capitalist letters Q3 2025 page for much capitalist letters from hedge funds and different starring investors.